(19)
(11) EP 1 781 107 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.12.2013 Bulletin 2013/51

(45) Mention of the grant of the patent:
28.08.2013 Bulletin 2013/35

(21) Application number: 05789229.1

(22) Date of filing: 24.08.2005
(51) International Patent Classification (IPC): 
A61K 36/258(2006.01)
A61K 36/718(2006.01)
A61P 9/12(2006.01)
 A61K 36/708(2006.01)
A61K 36/539(2006.01)
(86) International application number:
PCT/US2005/030040
(87) International publication number:
WO 2006/026284 (09.03.2006 Gazette 2006/10)

(54)

HERBAL PHARMACEUTICAL COMPOSITIONS FOR PROPHYLAXIS AND/OR TREATMENT OF CARDIOVASCULAR DISEASES AND THE METHOD OF PREPARING THE SAME

PFLANZLICHE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR PROPHYLAXE UND/ODER BEHANDLUNG VON KARDIOVASKULÄREN ERKRANKUNGEN UND HERSTELLUNGSVERFAHREN DAFÜR

COMPOSITIONS PHYTOPHARMACEUTIQUES POUR PREVENIR ET/OU TRAITER DES MALADIES CARDIO-VASCULAIRES ET PROCEDE POUR LES PREPARER

(84) Designated Contracting States:
DE FR GB

(30) Priority: 27.08.2004 US 927196

(43) Date of publication of application:
09.05.2007 Bulletin 2007/19

(73) Proprietor: SUNTEN PHYTOTECH CO., LTD.
Nangang Dist. Taipei City 11503 (CN)

(72) Inventors:
  • SHEN, Chung Guang
    Foster City, CA 94404 (US)
  • CHUANG, Wu-Chang
    Yonghe, Taipei, Taiwan (CN)

(74) Representative: Chajmowicz, Marion et al
Becker & Associés 25, rue Louis Le Grand
75002 Paris
75002 Paris (FR)


(56) References cited: : 
US-A1- 2003 124 206
US-B2- 6 656 464
 US-B2- 6 656 464
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).